Frontiers in Cardiovascular Medicine (Sep 2022)

Electrophysiological effects of adipose graft transposition procedure (AGTP) on the post-myocardial infarction scar: A multimodal characterization of arrhythmogenic substrate

  • Raquel Adeliño,
  • Daina Martínez-Falguera,
  • Daina Martínez-Falguera,
  • Carolina Curiel,
  • Albert Teis,
  • Albert Teis,
  • Albert Teis,
  • Roger Marsal,
  • Oriol Rodríguez-Leor,
  • Oriol Rodríguez-Leor,
  • Cristina Prat-Vidal,
  • Edgar Fadeuilhe,
  • Júlia Aranyó,
  • Elena Revuelta-López,
  • Elena Revuelta-López,
  • Axel Sarrias,
  • Víctor Bazan,
  • Joan F. Andrés-Cordón,
  • Santiago Roura,
  • Santiago Roura,
  • Santiago Roura,
  • Santiago Roura,
  • Roger Villuendas,
  • Roger Villuendas,
  • Josep Lupón,
  • Josep Lupón,
  • Josep Lupón,
  • Antoni Bayes-Genis,
  • Antoni Bayes-Genis,
  • Antoni Bayes-Genis,
  • Antoni Bayes-Genis,
  • Carolina Gálvez-Montón,
  • Carolina Gálvez-Montón,
  • Carolina Gálvez-Montón,
  • Felipe Bisbal,
  • Felipe Bisbal,
  • Felipe Bisbal

DOI
https://doi.org/10.3389/fcvm.2022.983001
Journal volume & issue
Vol. 9

Abstract

Read online

ObjectiveTo assess the arrhythmic safety profile of the adipose graft transposition procedure (AGTP) and its electrophysiological effects on post-myocardial infarction (MI) scar.BackgroundMyocardial repair is a promising treatment for patients with MI. The AGTP is a cardiac reparative therapy that reduces infarct size and improves cardiac function. The impact of AGTP on arrhythmogenesis has not been addressed.MethodsMI was induced in 20 swine. Contrast-enhanced magnetic resonance (ce-MRI), electrophysiological study (EPS), and left-ventricular endocardial high-density mapping were performed 15 days post-MI. Animals were randomized 1:1 to AGTP or sham-surgery group and monitored with ECG-Holter. Repeat EPS, endocardial mapping, and ce-MRI were performed 30 days post-intervention. Myocardial SERCA2, Connexin-43 (Cx43), Ryanodine receptor-2 (RyR2), and cardiac troponin-I (cTnI) gene and protein expression were evaluated.ResultsThe AGTP group showed a significant reduction of the total infarct scar, border zone and dense scar mass by ce-MRI (p = 0.04), and a decreased total scar and border zone area in bipolar voltage mapping (p < 0.001). AGTP treatment significantly reduced the area of very-slow conduction velocity (<0.2 m/s) (p = 0.002), the number of deceleration zones (p = 0.029), and the area of fractionated electrograms (p = 0.005). No differences were detected in number of induced or spontaneous ventricular arrhythmias at EPS and Holter-monitoring. SERCA2, Cx43, and RyR2 gene expression were decreased in the infarct core of AGTP-treated animals (p = 0.021, p = 0.018, p = 0.051, respectively).ConclusionAGTP is a safe reparative therapy in terms of arrhythmic risk and provides additional protective effect against adverse electrophysiological remodeling in ischemic heart disease.

Keywords